Current Members

PPTA members produce approximately 80% of the plasma protein therapies used in the United States today and more than 60% worldwide.

Global Members

Bio Products Laboratory
CSL Behring
Grifols
Kedrion SpA
Takeda

European Members

Bio Products Laboratory
CSL Behring GmbH
Grifols International SA
Kedrion SpA
Prothya Biosolutions Netherlands B.V.
Takeda

North America Members

ADMA Biologics, Inc.
Bio Products Laboratory
CSL Behring
Grifols
Kedrion SpA
Takeda

Source Members

ABO Plasma
Access Plasma LLC
B Positive Plasma LLC
BioLife Plasma Services LP/(Takeda)
Biomat USA LLC (Grifols)
BioTek America, LLC (dba Freedom Plasma)
BPL Plasma Inc.
Canadian Plasma Resources
CSL Plasma
Europlasma GmbH
Hemarus LLC
Immunotek Bio Centers LLC
Kamada Plasma, LLC
KEDPlasma LLC
Kedrion SpA
Octapharma Plasma
PlasmaVita
Prometic Plasma Resources
Scantibodies Biologics
Southern Blood Services
UNICAplasma s.r.o

Associate Members

Abbott Laboratories Diagnostic Division
ABO Pharmaceuticals
AOSS Medical Supply
Blood Centers of America (BCA)
Evolve Biologics Inc.
Fresenius Kabi
Haemonetics Corporation
Headspring Healthcare, Inc.
Hemasource
Kamada Ltd.
Lychem International Ltd.
Marketing Research Bureau Inc.
National Genetics Institute
Onbe
Paysign, Inc.
PreviPharma Consulting GmbH
QualTex Laboratories
Roche Diagnostics
Secure Transfusion Services
Terumo BCT
Vizient Inc.

Membership

PPTA News

A missed opportunity to acknowledge EU’s dependency on U.S. plasma +

Brussels, Belgium (December 17) The Plasma Protein Therapeutics Association (PPTA) regrets that the publication of the European Commission report, “Study on medicine shortages,” does not include plasma, which is a biological starting material for the manufacture of lifesaving plasma-derived medicinal products (PDMPs). PDMP availability is primarily dependent on volumes of plasma collected, which are currently insufficient to meet the needs of EU patients.
Read More
Adoption of the EP report “EU Pharmaceutical Strategy” +

Brussels, November 24 — The Plasma Protein Therapeutics Association (PPTA) congratulates MEP Montserrat (EPP, Spain) for the adoption of the report “EU Pharmaceutical Strategy” during the European Parliament’s Plenary session. The report was adopted by 527 MEPs on Wednesday 24 November.
Read More
The Telegraph continues maligning plasma donors +

In an article published on November 17 by Cara McGoogan, and in an accompanying podcast, The Telegraph returns to decades-old, sensationalized information to disparage plasma donors in the U.S. as well as the safety and efficacy of lifesaving plasma protein therapies.
Read More
International Plasma Awareness Week 2021: Donate Plasma. Save Lives. +

ANNAPOLIS, MD (October 4, 2021) — The Plasma Protein Therapeutics Association (PPTA) is proud to mark the launch of the ninth annual International Plasma Awareness Week (IPAW), which will run from Monday, October 4 until Friday, October 8. Nearly 125,000 people in the U.S. with rare diseases, and countless others facing trauma and emergency medical needs every day, rely on medicines that are only available because of the commitment of dedicated plasma donors. Considering the nearly 20% decline in plasma donations seen last year due to the ongoing pandemic, the need for plasma donors is now more urgent than ever before.
Read More

1
2
3

› ‹

The Source, the international magazine of the plasma protein therapeutics industry, is published three times a year.

Learn more about the need for plasma donors, plasma donation, and how you can save and improve lives.
Find a Donation Center.

The need for plasma and plasma donors is more urgent than ever before. Visit givingplasma.org to learn more and to find a donation center near you.

"How Is Your Day?" is an initiative to raise awareness of the unique nature of plasma protein therapies and the value they provide to patients. It aims to inform and educate decision makers and the general public worldwide.

Get involved and follow "How Is Your Day?" on social media @HIYDglobal

Media and Information

Advocacy

Copyright © 2020 PPTA. All rights reserved. (202) 789-3100

Terms of Use | Privacy Statement | Sitemap